190 likes | 208 Views
NAACCR / IACR Combined Annual Conference, Vancouver, Canada 9 th -13 th June 2019. Socio-economic position and prevalence of comorbidity in cancer patients in England: a population-based study of four cancers.
E N D
NAACCR / IACR Combined Annual Conference, Vancouver, Canada 9th-13th June 2019 Socio-economic position and prevalence of comorbidity in cancer patients in England: a population-based study of four cancers Helen Fowler, AurelienBelot, Libby Ellis, Camille Maringe, Miguel Angel Luque-Fernandez, Edmund Njeru Njagi, Neal Navani, Diana Sarfati, Bernard Rachet
Comorbidity • Existence of a long-term health condition in the presence of a primary disease of interest • Generally, more prevalent with older age and lower socio-economic position (SEP) • Less is known about prevalence of comorbidity in cancer patients • Can influence treatment and outcomes • SEP inequalities in cancer treatment and short-term mortality – due to comorbidity?
Aims of study Use electronic health records to estimate comorbidity prevalence in cancer patients, in order to: • Establish prominent comorbid conditions • Identify patterns in comorbidity by SEP (adjusting for age and sex) Four cancers: Colon, rectum, lung, Hodgkin lymphoma (HL)
Data England National Cancer Registry data • Patient / tumour information: • Age, sex, SEP (deprivation), type of cancer and date of diagnosis England hospital admissions records (“Hospital Episode Statistics”, HES) • Comorbidity information: • Diagnostic information, hospital admission and discharge dates
Fourteen conditions considered as comorbidities Timeframe for inclusion: Condition diagnosed up to six years prior to cancer diagnosis
Methods of analysis • Prevalence (percentage): crude, and adjusted for age and sex • Logistic regression: adjusted* odds ratio of a given condition being present • Multinomial logistic regression: adjusted* probability of condition being present as a single or (part of) multiple comorbidity *adjusted for age, sex and deprivation
Patients: 15-90 years at diagnosis No. of patients Sex Colon Rectum Lung HL Age Deprivation group Colon Rectum Lung HL
Patients: 15-90 years at diagnosis No. of patients Sex Colon Rectum Lung HL Age Deprivation group Colon Rectum Lung HL
Patients: 15-90 years at diagnosis No. of patients Sex Colon Rectum Lung HL Age Deprivation group Colon Rectum Lung HL
Comorbidity status by cancer type Percentage of patients with 0, 1 or 2+ comorbidities
Odds ratios of a given condition present, by deprivation group (Male colon cancer patients, aged 70 years) Deprivation group (1 = Least deprived, REF)
Odds ratios of a given condition present, by deprivation group (Male colon cancer patients, aged 70 years) Deprivation group (1 = Least deprived, REF)
Probability (%) of having condition as single or multiple comorbidity(Male colon cancer patients)
Probability (%) of having condition as single or multiple comorbidity(Female colon cancer patients)
Conclusions • Common prevalent conditions in each of the four cancers • Similar prevalence patterns by deprivation, age and sex • Deprivation was associated with almost all of 14 comorbid conditions, and with multiple comorbidity • Prevalence of some conditions may be underreported in hospital admissions data • Important insight for investigating the role of specific conditions on cancer outcomes
Acknowledgments Bernard Rachet AurelienBelot Libby Ellis Camille Maringe Miguel Angel Luque-Fernandez Edmund Njeru Njagi Neal Navani Diana Sarfati Michel Coleman Thank you!